Recombinant human erythropoietin mitigates reductions in renal klotho expression

Hidekazu Sugiura, Takumi Yoshida, Michihiro Mitobe, Shunji Shiohira, Kosaku Nitta, Ken Tsuchiya

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Background: Erythropoietin (EPO) and Klotho expression have both been detected in the kidney. Since a recent study suggested that both EPO and Klotho mitigate kidney damage, we explored the relation between EPO and Klotho in a doxorubicin hydrochloride (DXR)-induced rat nephropathy model treated with recombinant human erythropoietin (rhEPO). Methods: Male Sprague-Dawley rats were subjected to DXR-induced nephropathy. The rhEPO group was intracutaneously injected with rhEPO twice weekly at 4-16 weeks after the DXR injection. The rats were sacrificed at 16 weeks after the DXR administration. Expression of renal Klotho, HSP70, α-smooth-muscle actin and E-cadherin were assessed using real-Time PCR or western blotting. The hematocrit, plasma creatinine and phosphate levels were also determined. Immunohistochemical studies and Masson-Trichrome staining were performed. Results: The renal Klotho mRNA and Klotho protein expressions were significantly reduced in the DXR nephropathy group. Treatment with rhEPO improved the serum creatinine, phosphate level and histological changes observed in the DXR nephropathy group. The reduction in Klotho expression induced by DXR nephropathy was mitigated by rhEPO administration. Conclusion: rhEPO is involved in the pathophysiology of DXR nephropathy. rhEPO mitigated elevated plasma phosphate concentrations in an experimental model of chronic kidney disease via the expression of Klotho.

Original languageEnglish (US)
Pages (from-to)137-144
Number of pages8
JournalAmerican Journal of Nephrology
Volume32
Issue number2
DOIs
StatePublished - Jan 1 2010

Keywords

  • Anemia
  • Doxorubicin hydrochloride
  • Erythropoietin
  • Kidney injury
  • Klotho
  • Phosphate

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Recombinant human erythropoietin mitigates reductions in renal klotho expression'. Together they form a unique fingerprint.

  • Cite this

    Sugiura, H., Yoshida, T., Mitobe, M., Shiohira, S., Nitta, K., & Tsuchiya, K. (2010). Recombinant human erythropoietin mitigates reductions in renal klotho expression. American Journal of Nephrology, 32(2), 137-144. https://doi.org/10.1159/000315864